Search Results - "Brézault, C"

Refine Results
  1. 1

    Hepatitis B virus reactivation in patients with solid tumors receiving systemic anticancer treatment by Voican, C.S., Mir, O., Loulergue, P., Dhooge, M., Brezault, C., Dréanic, J., Chaussade, S., Pol, S., Coriat, R.

    Published in Annals of oncology (01-12-2016)
    “…Most drugs used for the treatment of solid tumors can induce hepatitis B reactivation in HBs antigen-positive patients. The risk is well documented for…”
    Get full text
    Journal Article
  2. 2

    The choice for the optimal therapy in advanced biliary tract cancers: Chemotherapy, targeted therapies or immunotherapy by Palmieri, L.-J., Lavolé, J., Dermine, S., Brezault, C., Dhooge, M., Barré, A., Chaussade, S., Coriat, R.

    Published in Pharmacology & therapeutics (Oxford) (01-06-2020)
    “…Biliary tract cancers (BTCs) represent a heterogeneous group that includes intrahepatic cholangiocarcinomas (CCAs), perihilar-CCAs or Klatskin tumors,…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer by Rubbia-Brandt, L., Audard, V., Sartoretti, P., Roth, A. D., Brezault, C., Le Charpentier, M., Dousset, B., Morel, P., Soubrane, O., Chaussade, S., Mentha, G., Terris, B.

    Published in Annals of oncology (01-03-2004)
    “…Background: In advanced metastatic colorectal adenocarcinoma, the addition of a neo-adjuvant systemic treatment to surgery might translate into a survival…”
    Get full text
    Journal Article
  5. 5

    Are targeted therapies or immunotherapies effective in metastatic pancreatic adenocarcinoma? by Rémond, M.S., Pellat, A., Brezault, C., Dhooge, M., Coriat, R.

    Published in ESMO open (01-12-2022)
    “…Metastatic pancreatic ductal adenocarcinoma (PDAC) is a major health burden due to its increasing incidence and poor prognosis. PDAC is characterized by a low…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Portal venous gas following chemotherapy for colorectal cancer liver metastasis by Zalinski, S, Scatton, O, Jacqmin, S, Tacher, V, Brézault, C, Soubrane, O

    Published in European journal of surgical oncology (01-05-2009)
    “…Abstract The standard of care for patients with colorectal liver metastases is a combination of chemotherapy and surgery. New chemotherapy regimens with…”
    Get full text
    Journal Article
  8. 8

    Hemolytic uremic syndrome as a complication of gemcitabine treatment: report of six cases and review of the literature by Desramé, J, Duvic, C, Bredin, C, Béchade, D, Artru, P, Brézault, C, Defuentes, G, Poirier, J M, Dourthe, L M, Coutant, G, Chaussade, S, de Gramont, A, Algayres, J P

    Published in La revue de medecine interne (01-03-2005)
    “…Hemolytic uremic syndrome is a rare condition during gemcitabine therapy. We report six new cases of hemolytic uremic syndrome related to gemcitabine, three…”
    Get full text
    Journal Article
  9. 9

    Overweight is associated to a better prognosis in metastatic colorectal cancer: A pooled analysis of FFCD trials by Barbier, Emilie, François, Eric, Michel, Pierre, Rougier, Philippe, Seitz, Jean-François, Aouakli, A., Bedjaoui, A., Botton, A., Cadier-Lagnes, A., Hollebecque, A., Lemaire, A., Marre, A., Villing, A.L., Denis, B., Becht, C., Bineau, C., Borel, C., Buffet, C., Cornila, C., Couffon, C., Locher, C., Rebischung, C., Sarda, C., Auby, D., Baudet-Klepping, D., Besson, D., Cleau, D., Festin, D., Genet, D., Peré-Vergé, D., Pillon, D., Smith, D., Dorval Danquechin, E., Maillard, E., Mitry, E., Suc, E., Zrihen, E., Pariente, E.A., Dewaele, F., Di Fiore, F., Husseini, F., Kikolski, F., Petit-Laurent, F., Zerouala-Boussaha, F., Caroli-Bosc, F.X., Boilleau-Jolimoy, G., Medinger, G., Graber, I., Charneau, J., Cretin, J., Deguiral, J., Lacourt, J., Meunier, J., Vincent, J., Volet, J., Barbare, J.C., Paitel, J.F., Raoul, J.L., Gornet, J.M., Aucouturier, J.P., Barbieux, J.P., Plachot, J.P., Ramain, J.P., Spano, J.P., Bouhier-Leporrier, K., Cany, L., Rob, L., Baconnier, M., Benchalal, M., Combe, M., Duluc, M., Giovannini, M., Mabro, M., Ramdani, M., Tissot, M., Clavero-Fabri, M.C., Gouttebel, M.C., Kaminsky, M.C., Stremsdoerfer, N., Burtin, P., Cassan, P., Claudé, P., Couzigou, P., Geoffroy, P., Godeau, P., Hammel, P., Novello, P., Prost, P., Ruszniewski, P., Texereau, P., Coriat, R., Nasca, S., Fratte, S.P., Mansourbakht, T., Walter, T., Derias, V., Jestin Le Tallec, V., Sebbagh, V., Adhoute, X., Becouarn, Y.

    Published in European journal of cancer (1990) (01-07-2018)
    “…Previous studies showed that high and low body mass index (BMI) was associated with worse prognosis in early-stage colorectal cancer (CRC), and low BMI was…”
    Get full text
    Journal Article
  10. 10

    Computed tomography scan efficacy in staging gastric linitis plastica lesion: a retrospective multicentric French study by Morgant, Stéphanie, Artru, Pascal, Oudjit, Ammar, Lourenco, Nelson, Pasquer, Arnaud, Walter, Thomas, Gornet, Jean-Marc, Rouquette, Alexandre, Lledo, Gérard, Brezault, Catherine, Coriat, Romain

    Published in Cancer management and research (01-01-2018)
    “…Computed tomography (CT) scan is a key imaging technique in the staging of gastric adenocarcinoma and therapeutic management of patients. The aim of this study…”
    Get full text
    Journal Article
  11. 11

    Application of ANAES guidelines for colonoscopy in France: A practical survey by Huppertz, J., Coriat, R., Leblanc, S., Gaudric, M., Brezault, C., Grandjouan, S., Chaput, U., Prat, F., Chaussade, S.

    Published in Gastroentérologie clinique et biologique (01-10-2010)
    “…In 2004, the French health authorities published guidelines on the indications for colonoscopy. However, no study has evaluated the awareness of healthcare…”
    Get full text
    Journal Article
  12. 12

    Hereditary Non-polyposis Colorectal Cancer: Prevention and Therapeutic Options by Dhooge, M., Coriat, R., Grandjouan, S., Brezault, C., Dréanic, J., Chaussade, S.

    Published in Current colorectal cancer reports (01-06-2015)
    “…Lynch syndrome (LS), also known as hereditary non-polyposis colorectal cancer (HNPCC), is the most common hereditary colorectal cancer (CRC) syndrome. The…”
    Get full text
    Journal Article
  13. 13

    Syndrome hémolytique et urémique secondaire à la gemcitabine : à propos de six observations et revue de la littérature by Desramé, J., Duvic, C., Bredin, C., Béchade, D., Artru, P., Brézault, C., Defuentes, G., Poirier, J.M., Dourthe, L.M., Coutant, G., Chaussade, S., de Gramont, A., Algayres, J.P.

    Published in La revue de medecine interne (01-03-2005)
    “…Le syndrome hémolytique et urémique est une complication rare des traitements par gemcitabine. Méthodes. – Nous rapportons une série de six nouveaux cas de…”
    Get full text
    Journal Article
  14. 14

    Feasibility of gemcitabine and oxaliplatin in patients with advanced biliary tract carcinoma and a performance status of 2 by Mir, Olivier, Coriat, Romain, Dhooge, Marion, Perkins, Géraldine, Boudou-Rouquette, Pascaline, Brezault, Catherine, Ropert, Stanislas, Durand, Jean-Philippe, Chaussade, Stanislas, Goldwasser, François

    Published in Anti-cancer drugs (01-08-2012)
    “…The use of gemcitabine and oxaliplatin is well documented in selected patients with advanced biliary tract carcinoma (BTC), but little is known on the…”
    Get full text
    Journal Article
  15. 15

    Quality control of colonoscopy procedures: A prospective validated method for the evaluation of professional practices applicable to all endoscopic units by Coriat, R., Pommaret, E., Chryssostalis, A., Viennot, S., Gaudric, M., Brezault, C., Lamarque, D., Roche, H., Verdier, D., Parlier, D., Prat, F., Chaussade, S.

    Published in Gastroentérologie clinique et biologique (01-02-2009)
    “…To produce valid information, an evaluation of professional practices has to assess the quality of all practices before, during and after the procedure under…”
    Get full text
    Journal Article
  16. 16

    Cervical extravasation of bevacizumab by Dréanic, Johann, Coriat, Romain, Mir, Olivier, Perkins, Géraldine, Boudou-Rouquette, Pascaline, Brezault, Catherine, Dhooge, Marion, Goldwasser, François, Chaussade, Stanislas

    Published in Anti-cancer drugs (01-04-2013)
    “…Monoclonal antibodies such as bevacizumab are widely used in medical oncology, either alone or in combination with chemotherapy. No specific recommendations on…”
    Get full text
    Journal Article
  17. 17

    Protection against oxaliplatin acute neurosensory toxicity by venlafaxine by Durand, Jean-Philippe, Brezault, Catherine, Goldwasser, François

    Published in Anti-cancer drugs (01-07-2003)
    “…Venlafaxine (Effexor; Wyeth Lederlé) has previously shown therapeutic effects for the management of chronic and neuropathic pains. We report here the efficacy…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Protection against oxaliplatin acute neurosensory toxicity by venlafaxine by Durand, J-P, Brezault, C, Goldwasser, F

    Published in Anti-cancer drugs (01-07-2003)
    “…Venlafaxine (Effexor; Wyeth Lederle) has previously shown therapeutic effects for the management of chronic and neuropathic pains, We report here the efficacy…”
    Get full text
    Journal Article
  20. 20

    Chronotherapy of colorectal cancer metastases by Lévi, F, Giacchetti, S, Zidani, R, Brezault-Bonnet, C, Tigaud, J M, Goldwasser, F, Misset, J L

    Published in Hepato-gastroenterology (01-03-2001)
    “…Chronotherapy has consisted in the adaptation of chemotherapeutic drug delivery to circadian (approximately 24-hour) rhythms. This can be achieved in fully…”
    Get more information
    Journal Article